Endocrine therapy is effective treatment for patients with metastatic prostate cancer. Most patients will benefit from androgen withdrawal in terms of symptomatic relief and delay in progression of diseases. It does not, however, cure patients with metastatic prostate cancer. This finding emphasizes the need for the development of effective nonendocrine therapies.
CITATION STYLE
Bare, R. L., & Torti, F. M. (1998). Endocrine therapy of prostate cancer. Cancer Treatment and Research. https://doi.org/10.1007/978-1-4615-6189-7_5
Mendeley helps you to discover research relevant for your work.